documents: FDA-2017-D-5625-0005

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id agency_id docket_id title document_type subtype posted_date posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2017-D-5625-0005 FDA FDA-2017-D-5625 Recommendations for Dual 510(k) and Clinical Laboratory Improvement Amendments Waiver by Application Studies; Draft Guidance for Industry and Food and Drug Administration Staff; Availability; Extension of Comment Period Notice Notice of Availability 2018-01-26T05:00:00Z 2018 1 2018-01-26T05:00:00Z 2018-03-31T03:59:59Z 2018-03-31T01:00:39Z 2018-01350 0 0 0900006482e6c0cd

Links from other tables